• Dear Guest, Please note that adult content is not permitted on this forum. We have had our Google ads disabled at times due to some posts that were found from some time ago. Please do not post adult content and if you see any already on the forum, please report the post so that we can deal with it. Adult content is allowed in the glory hole - you will have to request permission to access it. Thanks, scara

Coronavirus

Honestly, don’t waste your time. It’s not even high level.

View attachment 11393


Who runs the site? Who benefits from plenty of visitors posting?
Nice conspiracy theory, but it doesn't pass a sense check.

If I doubled the number of visitors to this site it would make less in a month than an hour of my time is worth. That would be a very inefficient use of my time.
 
I had to do a double-take on this. How many lives is your 'freedom' worth, just to put a figure on it?

(edit : I've just noticed we're on page 666...fancy that)

Scara's not "free", he is apparently a prisoner of his own claminess. Let us pray for his release.
 
I wonder how they go about introducing additional vaccines such as this given the logistics of the second doses. Does it go nationwide with the associated jeopardy of matching people up again to each particular vaccine for dose 2.
I would assume it would be introduced only for new first dose appointments, but you never know nowadays. Could be just as likely that we run out of one and they have to scramble together a press release that mixing and matching is perfectly fine!

Way ahead of you...

https://www.nihr.ac.uk/news/worlds-...e-alternating-dose-study-launches-in-uk/26773

The world’s first COVID-19 vaccine study researching alternating doses of two approved vaccines - alongside different dosing intervals, begins today (February 4th) at eight research sites across England.

The National Institute for Health Research (NIHR) supported study, referred to as the COVID-19 Heterologous Prime Boost study, or ‘Com-Cov’, will determine the effects of using a different approved vaccine for the second dose to the first dose, in addition to examining the efficacy of two different time intervals between doses.

Over 800 volunteers, aged 50-years-old and above, are expected to take part in the study at eight sites across England - including in Oxford, London, Birmingham, Liverpool, Nottingham, Bristol and Southampton.


https://www.nature.com/articles/d41586-021-00315-5

Vaccine developers often combine two vaccines to combat the same pathogen, and researchers are keen to deploy the strategy — known as a heterologous prime-boost — against the coronavirus. A heterologous prime-boost combination was approved last year by European regulators to protect against Ebola, and experimental HIV vaccines often rely on the strategy

 
Way ahead of you...

https://www.nihr.ac.uk/news/worlds-...e-alternating-dose-study-launches-in-uk/26773

The world’s first COVID-19 vaccine study researching alternating doses of two approved vaccines - alongside different dosing intervals, begins today (February 4th) at eight research sites across England.

The National Institute for Health Research (NIHR) supported study, referred to as the COVID-19 Heterologous Prime Boost study, or ‘Com-Cov’, will determine the effects of using a different approved vaccine for the second dose to the first dose, in addition to examining the efficacy of two different time intervals between doses.

Over 800 volunteers, aged 50-years-old and above, are expected to take part in the study at eight sites across England - including in Oxford, London, Birmingham, Liverpool, Nottingham, Bristol and Southampton.


https://www.nature.com/articles/d41586-021-00315-5

Vaccine developers often combine two vaccines to combat the same pathogen, and researchers are keen to deploy the strategy — known as a heterologous prime-boost — against the coronavirus. A heterologous prime-boost combination was approved last year by European regulators to protect against Ebola, and experimental HIV vaccines often rely on the strategy

Thanks for posting Steve, really interesting.
 
Way ahead of you...

https://www.nihr.ac.uk/news/worlds-...e-alternating-dose-study-launches-in-uk/26773

The world’s first COVID-19 vaccine study researching alternating doses of two approved vaccines - alongside different dosing intervals, begins today (February 4th) at eight research sites across England.

The National Institute for Health Research (NIHR) supported study, referred to as the COVID-19 Heterologous Prime Boost study, or ‘Com-Cov’, will determine the effects of using a different approved vaccine for the second dose to the first dose, in addition to examining the efficacy of two different time intervals between doses.

Over 800 volunteers, aged 50-years-old and above, are expected to take part in the study at eight sites across England - including in Oxford, London, Birmingham, Liverpool, Nottingham, Bristol and Southampton.


https://www.nature.com/articles/d41586-021-00315-5

Vaccine developers often combine two vaccines to combat the same pathogen, and researchers are keen to deploy the strategy — known as a heterologous prime-boost — against the coronavirus. A heterologous prime-boost combination was approved last year by European regulators to protect against Ebola, and experimental HIV vaccines often rely on the strategy


I am awestuck you just quoted Nature at me. This is a football forum.
 
Thankfully I have a different value system to you. One where my relationship to other people is not viewed transactionally or through a monetary lens.
What about people you don't even know exist? What happens the moment they snuff out of existence, other than your heart taking another beat?
 
Back